Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | tert-Butyl 2,5-dimethylpiperazine-1-carboxylate | HCID 22625934 | — |
| Reactant | HCID 69514546 | HCID 69514546 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 21101941 | HCID 21101941 | 25% |
Reaction Steps
Sodium hydride (72 mg, 3 mmol) is added to a solution of 7-chloro-4-quinolone (359 mg, 2 mmol) in DMF. After 1 h at 40° C. N-phenyl(trifluoromethylsulfon)imide (1.0 g, 2.8 mmol) and, 1 h later, 1-tert-butoxycarbonyl-2,5-dimethylpiperazine (1.8 g, 8 mmol) is added. The reaction mixture is stirred at 80° C. for 2 days, concentrated, diluted with EtOAc, washed with water and brine, dried (Na2SO4), and concentrated. The residue is purified by reversed phase HPLC with water-MeCN-TFA to give 4-[4-(tert-butoxycarbonyl)-2,5-dimethylpiperazin-1-yl]-7-chloroquinoline (188 mg, 0.5 mmol) which is deprotected with TFA in CH2Cl2 and transformed after being washed with base into the product with 4-fluorophenyl isocyanate (31 μL, 0.27 mmol) according to method C giving the title product as a colorless solid.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07220856B2 |
|---|
| Source dataset | uspto-grants-2007_05 |
|---|
| ORD ID | ord-79e5523f9ec94601abf16d5f4ceb4712 |
|---|
| Source note | uspto-grants-2007_05 |
|---|